AU2002249108A1 - Regulation of human b7-h2 protein - Google Patents

Regulation of human b7-h2 protein

Info

Publication number
AU2002249108A1
AU2002249108A1 AU2002249108A AU2002249108A AU2002249108A1 AU 2002249108 A1 AU2002249108 A1 AU 2002249108A1 AU 2002249108 A AU2002249108 A AU 2002249108A AU 2002249108 A AU2002249108 A AU 2002249108A AU 2002249108 A1 AU2002249108 A1 AU 2002249108A1
Authority
AU
Australia
Prior art keywords
protein
regulation
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249108A
Other languages
English (en)
Inventor
Jeffrey Encinas
Eri Tanabe
Shinichi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002249108A1 publication Critical patent/AU2002249108A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70532—B7 molecules, e.g. CD80, CD86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002249108A 2001-01-04 2002-01-04 Regulation of human b7-h2 protein Abandoned AU2002249108A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25963201P 2001-01-04 2001-01-04
US60/259,632 2001-01-04
PCT/EP2002/000028 WO2002053733A2 (en) 2001-01-04 2002-01-04 Regulation of human b7-h2 protein

Publications (1)

Publication Number Publication Date
AU2002249108A1 true AU2002249108A1 (en) 2002-07-16

Family

ID=22985715

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002249108A Abandoned AU2002249108A1 (en) 2001-01-04 2002-01-04 Regulation of human b7-h2 protein

Country Status (5)

Country Link
US (1) US20040152156A1 (enExample)
EP (1) EP1349936A2 (enExample)
JP (1) JP2004527228A (enExample)
AU (1) AU2002249108A1 (enExample)
WO (1) WO2002053733A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160145344A1 (en) * 2014-10-20 2016-05-26 University Of Southern California Murine and human innate lymphoid cells and lung inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2362126C (en) * 1999-02-03 2017-01-17 Amgen Inc. B7rp-1 polypeptides
WO2001064704A1 (en) * 2000-03-02 2001-09-07 Mayo Foundation For Medical Education And Research hB7-H2, A NOVEL CO-STIMULATORY MOLECULE
WO2002010187A1 (en) * 2000-07-27 2002-02-07 Mayo Foundation For Medical Education And Research B7-h3 and b7-h4, novel immunoregulatory molecules

Also Published As

Publication number Publication date
WO2002053733A2 (en) 2002-07-11
EP1349936A2 (en) 2003-10-08
JP2004527228A (ja) 2004-09-09
US20040152156A1 (en) 2004-08-05
WO2002053733A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2001254790A1 (en) Regulation of human cyslt2-like gpcr protein
AU2003266271A1 (en) Regulation of human esterase
AU2002249108A1 (en) Regulation of human b7-h2 protein
AU2001244205A1 (en) Regulation of human p2y-like gpcr protein
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases
AU2002308267A1 (en) Regulation of human icos v protein
AU2002247691A1 (en) Regulation of human elongase hselo1-like protein
AU2003271651A1 (en) Regulation of human pp2c-like protein phosphatase
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2002231620A1 (en) Regulation of human patched-like protein
AU2002219046A1 (en) Regulation of human ceruloplasmin-like protein
AU2002352145A1 (en) Regulation of human aldose reductase-like protein
AU2002250900A1 (en) Regulation of human elongase hselo1-like protein
AU2002237225A1 (en) Regulation of human patched-like protein
AU2002333490A1 (en) Regulation of human ptpase-like protein
AU2002325950A1 (en) Regulation of human mrp1-like protein
AU2003240706A1 (en) Regulation of human rhomboid-related protein
AU2002218196A1 (en) Regulation of human adam-ts-like protein
AU2001263814A1 (en) Regulation of human oatp2-related protein
AU2001262133A1 (en) Regulation of human nedd1-related protein
AU2002219083A1 (en) Regulation of human oat-like protein
AU2002308122A1 (en) Regulation of human gnat acetyltransferase-like protein
AU2002302494A1 (en) Regulation of human phosphatase-like protein
AU2002302506A1 (en) Regulation of human phosphatase-like protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase